An Investigator- And Subject-Blind Phase 1 Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of PF-04447943 After Administration Of Single Oral Doses To Healthy Young Adult Japanese Subjects And Multiple Oral Doses To Healthy Elderly Japanese Subjects.
Phase of Trial: Phase I
Latest Information Update: 15 Jan 2010
At a glance
- Drugs PF 4447943 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
- 11 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Dec 2009 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 17 Sep 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.